Bioanalytical Testing Services Market Size & Share, by Type (Cell-Based, In Vitro Virology, Biomarker, Pharmacokinetic, Serology); Molecule Type (Small Molecules, Large Molecules); Application (Cardiology, Gastroenterology, Neurology, Oncology); End-user (Pharmaceutical & Biopharmaceutical Institutions, Contract Research Organizations) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4227
  • Published Date: Feb 27, 2023
  • Report Format: PDF, PPT

Top Featured Companies Dominating the Global Bioanalytical Testing Services Market

top-features-companies
    • Charles River Laboratories, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Vipragen Biosciences Private Limited
    • Medpace Holdings, Inc.
    • Pace Analytical Services, LLC
    • WuXiAppTec Co., Ltd.
    • Eurofins Scientific SE
    • Intertek Group plc
    • SGS S.A.
    • Almac Group
    • BioAgilytix Labs

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Pace Analytical Services, LLC to receive approval for its Pace, a method to detect dibenzofurans and dioxins with the assistance of technology called GCMS/MS.

  • Medpace Holdings, Inc. to elaborate on avoiding basic pitfalls in clinical trials associated with cell therapy. The experts of Medpace Holdings, Inc. bring light to strategies and challenges by including various range of topics such as the capacity of clinical trials, managing complex logistics, regulatory strategy, and others.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4227
  • Published Date: Feb 27, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Escalating development of novel drugs and therapies, significant growth in blood donation, and spiking number of medication errors are some major factors driving the growth of the market.

The market is anticipated to attain a CAGR of ~9% over the forecast period, i.e., 2023 – 2035.

Requirement for higher initial investment, complex and long-lasting procedure of bioanalytical testing, and lack of skilled medical professional are the challenges affecting the market growth.

The market in North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Vipragen Biosciences Private Limited, Medpace Holdings, Inc., Pace Analytical Services, LLC, WuXiAppTec Co., Ltd., Eurofins Scientific SE, Intertek Group plc, SGS S.A., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, molecule type, application, end-user, and by region.

The small molecules segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying